Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mulligan

Showing results (191-200 of 245) with videos related to

Pageof 25
Sort By:
Journal of Occupational and Environmental Hygiene|January 28, 2005
A simultaneous job- and task-based exposure evaluation of petroleum tanker drivers to benzene and total hydrocarbonsDave K Verma, Wai K Cheng, Don S Shaw, et al.
Hemasphere|February 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemiaRaúl Córdoba, Stephan Stilgenbauer, Paolo Ghia, et al.
Leukemia & Lymphoma|November 24, 2022
Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient ProgramStephen P Mulligan, Stephen Opat, Chan Y Cheah, et al.
Oncotarget|November 12, 2015
The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemiaKimberley L Kaufman, Yiping Jenkins, Munther Alomari, et al.
Internal Medicine Journal|July 27, 2025
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitorsMary Ann Anderson, Farrukh T Awan, Leanne Berkahn, et al.
Neuroscience Letters|October 5, 2010
Correlated cerebral events between physically and sensory isolated pairs of subjects exposed to yoked circumcerebral magnetic fieldsM A Persinger, K S Saroka, C F Lavallee, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 5, 2017
Surface Profiling of Extracellular Vesicles from Plasma or Ascites Fluid Using DotScan Antibody MicroarraysLarissa Belov, Susannah Hallal, Kieran Matic, et al.
Neurophotonics|October 7, 2017
Mean and variability in functional brain activations differentially predict executive function in older adults: an investigation employing functional near-infrared spectroscopyDrew W R Halliday, Bryce P Mulligan, Douglas D Garrett, et al.
Leukemia & Lymphoma|January 20, 2026
The spectrum of tonsillar involvement in chronic lymphocytic leukemia (CLL)Anthony Jeffrey, George Mason, Luke Coyle, et al.
Internal Medicine Journal|March 21, 2025
Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry reportArina Martynchyk, Cameron Wellard, Eliza Chung, et al.
Pageof 25

Showing results (191-200 of 245) with videos related to

Sort By:
Pageof 25
Journal of Occupational and Environmental Hygiene|January 28, 2005
A simultaneous job- and task-based exposure evaluation of petroleum tanker drivers to benzene and total hydrocarbonsDave K Verma, Wai K Cheng, Don S Shaw, et al.
Hemasphere|February 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemiaRaúl Córdoba, Stephan Stilgenbauer, Paolo Ghia, et al.
Leukemia & Lymphoma|November 24, 2022
Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient ProgramStephen P Mulligan, Stephen Opat, Chan Y Cheah, et al.
Oncotarget|November 12, 2015
The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemiaKimberley L Kaufman, Yiping Jenkins, Munther Alomari, et al.
Internal Medicine Journal|July 27, 2025
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitorsMary Ann Anderson, Farrukh T Awan, Leanne Berkahn, et al.
Neuroscience Letters|October 5, 2010
Correlated cerebral events between physically and sensory isolated pairs of subjects exposed to yoked circumcerebral magnetic fieldsM A Persinger, K S Saroka, C F Lavallee, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 5, 2017
Surface Profiling of Extracellular Vesicles from Plasma or Ascites Fluid Using DotScan Antibody MicroarraysLarissa Belov, Susannah Hallal, Kieran Matic, et al.
Neurophotonics|October 7, 2017
Mean and variability in functional brain activations differentially predict executive function in older adults: an investigation employing functional near-infrared spectroscopyDrew W R Halliday, Bryce P Mulligan, Douglas D Garrett, et al.
Leukemia & Lymphoma|January 20, 2026
The spectrum of tonsillar involvement in chronic lymphocytic leukemia (CLL)Anthony Jeffrey, George Mason, Luke Coyle, et al.
Internal Medicine Journal|March 21, 2025
Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry reportArina Martynchyk, Cameron Wellard, Eliza Chung, et al.
Pageof 25